Corticotropin Releasing Hormone (CRH)
Human corticotropin-releasing hormone (CRH) is an amidated 41- amino acid peptide secreted by hypothalamic peptidergic neurons of the parvicellular neurosecretory cells along with other hypothalamic peptide hormones including thyrotropin releasing hormone (TRH), gonadotropin releasing hormone (GnRH), growth hormone releasing hormone (GHRH), somatostatin and vasoactive intestinal peptide (VIP). These hormones are stored in a small dense vesicle at the axon terminals close to the hypophysial portal system capillaries and under stimulation, are released in the hypophysial portal system to the anterior pituitary gland. In the anterior pituitary, CRH acts on the corticotrophs increases the rate of transcription of the POMC gene that encodes the corticotropin prohormone.
Administration of CRH stimulates secretion of adrenocorticotropic hormone (ACTH) from the pituitary. Therefore, the function of CRH is to regulate the secretion of ACTH from the pituitary, which in turn regulates the secretion of various corticosteroids hormones including cortisol from the adrenals. Increased concentration of cortisol or administration of glucocorticoids decreases the release of CRH and ACTH. Conversely, decreased concentration of cortisol leads increased synthesis of CRH. Therefore, serum concentration of CRH may be altered in adrenal hypo- or hyper-function. CRH is rarely measured in clinical laboratories for the assessment of adrenal dysfunction.
- Provide valuable information in the differential diagnosis of secondary adrenal insufficiency
- Useful in diagnosis of hypothalamic diseases
- Aid in diagnosis of hypothalamic-pituitary-adrenal axis dysfunction
Increased in:
- Addison’s disease
- Adrenalectomy
- Autoimmune adrenalitis
- Chronic kidney disease mineral bone disease (CKD-MBD)
- Ectopic CRH secretion by tumor (rare)
Decreased in:
- Tertiary adrenal insufficiency
- Hypothalamic disorder
- Long term glucocorticoid administration
- Cushing’s syndrome
- Cushing’s disease
- Ectopic ACTH secretion by tumor (most commonly in carcinoma of bronchus and carcinoid tumor)
- Adrenal adenoma
- Adrenal carcinoma
0.77 – 2.5 pmol/L
Plasma (EDTA) or Serum (SST).
Stability
- Ambient: Not recommended
- Refrigerated: 1 day
- Frozen: 30 days
- Acta Endocrinol (Copenh). 1993;128(6):503-7. [PMID: 8393256]
- Pituitary. 2019;22(5):561-568. [PMID: 31041631]
- J Clin Endocrinol Metab. 1998;83(5):1485-8. [PMID: 9589643]
- LOW MJ. Neuroendocrinology. In Williams Textbook of Endocrinology. 12th ed. Saunders Company: Philadelphia, PA; 2011. Page 103-174
- Bertholf RL, Copper M, Winter WE. Adrenal Cortex. Textbook of Clinical Chemistry and Molecular Diagnostics. 6th ed. 2018. Page 1530-1571.